Big Opportunity: Golden Decade of Defence Stocks in India
Here is the latest financial fact sheet of BALAXI PHARMA. For more details, see the BALAXI PHARMA quarterly results and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.7 |
No. of shares | m | 10.18 |
1 Week | % | 2.1 |
1 Month | % | 1.5 |
1 Year | % | 33.5 |
52 week H/L | Rs | 706.0/303.6 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
BALAXI PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | 702 | |
Low | Rs | NA | NA | NA | NA | 342 | |
Sales per share (Unadj.) | Rs | 0 | 44.7 | 45.6 | 231.3 | 279.4 | |
Earnings per share (Unadj.) | Rs | -2.5 | 6.5 | 6.1 | 38.1 | 47.7 | |
Diluted earnings per share | Rs | -0.8 | 1.9 | 6.0 | 37.5 | 46.8 | |
Cash flow per share (Unadj.) | Rs | -2.5 | 6.5 | 6.1 | 38.4 | 48.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0.50 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.49 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0.1 | |
Book value per share (Unadj.) | Rs | 5.1 | 11.6 | 27.7 | 65.0 | 113.2 | |
Adj. book value per share | Rs | 1.5 | 3.5 | 27.3 | 63.8 | 111.1 | |
Shares outstanding (eoy) | m | 3.04 | 3.04 | 10.00 | 10.00 | 10.00 | |
Price / Sales ratio | x | 0 | 0 | 0 | 0 | 1.9 | |
Avg P/E ratio | x | 0 | 0 | 0 | 0 | 10.9 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | 10.8 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | 4.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 1.0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | 5,218 | |
Total wages/salary | Rs m | 2 | 9 | 21 | 85 | 125 |
BALAXI PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 136 | 456 | 2,313 | 2,794 | |
Other income | Rs m | 0 | 9 | 6 | 22 | 50 | |
Total revenues | Rs m | 0 | 145 | 462 | 2,336 | 2,844 | |
Gross profit | Rs m | -8 | 16 | 83 | 427 | 508 | |
Depreciation | Rs m | 0 | 0 | 0 | 3 | 5 | |
Interest | Rs m | 0 | 0 | 0 | 3 | 8 | |
Profit before tax | Rs m | -8 | 24 | 88 | 443 | 545 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 5 | 27 | 62 | 69 | |
Profit after tax | Rs m | -8 | 20 | 61 | 381 | 477 | |
Gross profit margin | % | 0 | 11.5 | 18.1 | 18.4 | 18.2 | |
Effective tax rate | % | 0 | 19.4 | 30.6 | 14.0 | 12.6 | |
Net profit margin | % | 0 | 14.5 | 13.4 | 16.5 | 17.1 |
BALAXI PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 16 | 58 | 349 | 938 | 1,410 | |
Current liabilities | Rs m | 1 | 26 | 82 | 347 | 633 | |
Net working cap to sales | % | 0 | 23.5 | 58.4 | 25.5 | 27.8 | |
Current ratio | x | 12.5 | 2.2 | 4.2 | 2.7 | 2.2 | |
Inventory Days | Days | 0 | 9 | 7 | 5 | 8 | |
Debtors Days | Days | 0 | 146,964 | 2,377 | 1,211 | 374 | |
Net fixed assets | Rs m | 0 | 3 | 11 | 59 | 355 | |
Share capital | Rs m | 30 | 30 | 100 | 100 | 100 | |
"Free" reserves | Rs m | -15 | 5 | 177 | 550 | 1,032 | |
Net worth | Rs m | 16 | 35 | 277 | 650 | 1,132 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 17 | 61 | 360 | 997 | 1,765 | |
Interest coverage | x | 0 | 1,221.0 | 184.2 | 160.5 | 72.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0 | 2.2 | 1.3 | 2.3 | 1.6 | |
Return on assets | % | -45.6 | 32.2 | 17.1 | 38.5 | 27.4 | |
Return on equity | % | -49.5 | 55.8 | 22.0 | 58.7 | 42.1 | |
Return on capital | % | -49.5 | 69.3 | 31.9 | 68.6 | 48.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 136 | 456 | 869 | 1,000 | |
Fx outflow | Rs m | 0 | 0 | 10 | 110 | 87 | |
Net fx | Rs m | 0 | 136 | 447 | 759 | 913 |
BALAXI PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -7 | -15 | -140 | 0 | 341 | |
From Investments | Rs m | -0 | -0 | -2 | -60 | -284 | |
From Financial Activity | Rs m | 0 | 0 | 181 | 36 | -2 | |
Net Cashflow | Rs m | -7 | -15 | 39 | -23 | 55 |
Share Holding
Shareholding as on Dec 2022
|
Company Information
|
CHM: Ashish Maheshwari | COMP SEC: Nidhin Jose | YEAR OF INC: 1942 | NSE CODE: 911309 | FV (Rs): 10 | DIV YIELD (%): 0.1 |
More Trading Company Fact Sheets: CIPLA AUROBINDO PHARMA PIRAMAL ENTERPRISES LUPIN SUN PHARMA
Compare BALAXI PHARMA With: CIPLA AUROBINDO PHARMA PIRAMAL ENTERPRISES LUPIN SUN PHARMA
After opening the day on a positive note, Indian share markets continued their momentum throughout the trading session and ended on a firm footing.